PROTAC BRD4 Degrader-49

Overview

BRD4 degrader-8 is a BRD4 -targeting degrader. BRD4 degrader-8 induces degradation of BRD4 protein via the ubiquitin-proteasome pathway. BRD4 degrader-8 can be used for the research of hematologic tumors, gastrointestinal stromal tumors, histiocytic lymphoma, non-small cell lung cancer , small cell lung cancer , lung adenocarcinoma, lung squamous cell carcinoma, pancreatic cancer , breast cancer , prostate cancer , liver cancer , skin cancer , epithelial cell carcinoma, colorectal cancer , kidney cancer , gastric cancer , head and neck cancer , nasopharyngeal cancer . (Pink: BRD4 ligand ( HY-185884 ); Blue: VHL ligand ( HY-125845 ); Black: linker).

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-185854
• CAS No.: 3115940-40-1
• Molecular Formula: C53H67N9O6S2
• Molecular Weight: 990.29
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source